精神分裂症患者的宗教信仰会影响药物依从性吗？
Does religiosity in persons with schizophrenia influence medication adherence.
作者信息
Triveni Davuluri, Grover Sandeep, Chakrabarti Subho
机构信息
Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
出版信息
Indian J Psychiatry. 2021 May-Jun;63(3):228-232. doi: 10.4103/psychiatry.IndianJPsychiatry_413_20. Epub 2021 Jun 17.
BACKGROUND
Little information is available regarding the effect of religiosity and spirituality on medication adherence in patients with schizophrenia.
AIM
This study aimed to evaluate the association of medication adherence with different aspects of religiosity and spirituality in patients with schizophrenia.
MATERIALS AND METHODS
One hundred patients with schizophrenia were evaluated on religiousness measure scale and Duke Religion Index (DUREL); Brief Religious Coping Scale (Brief RCOPE); World Health Organization Quality of Life Spirituality, Religiosity, and Personal Beliefs (WHOQoL-SRPB); and Brief Adherence Rating Scale (BARS).
RESULTS
A higher level of religiosity as assessed by the religiousness measure scale, private religious activities and intrinsic religiosity as per DUREL, positive religious coping, and all the domains of WHOQOL-SRPB was associated with better medication compliance as assessed by the percentage of doses of medications consumed in the last 1 month as evaluated by using BARS.
CONCLUSION
The present study suggests that a higher level of religiosity and spirituality were associated with better medication compliance.
背景
关于宗教信仰和精神性对精神分裂症患者药物依从性的影响，现有信息较少。
目的
本研究旨在评估精神分裂症患者药物依从性与宗教信仰和精神性不同方面之间的关联。
材料与方法
对100名精神分裂症患者进行宗教信仰量表、杜克宗教指数（DUREL）、简易宗教应对量表（Brief RCOPE）、世界卫生组织生活质量-精神性、宗教信仰和个人信念量表（WHOQoL-SRPB）以及简易依从性评定量表（BARS）评估。
结果
通过宗教信仰量表评估的较高宗教信仰水平、DUREL中的私人宗教活动和内在宗教信仰、积极的宗教应对方式以及WHOQOL-SRPB的所有领域，与使用BARS评估的过去1个月内药物服用剂量百分比所反映的更好的药物依从性相关。
结论
本研究表明，较高水平的宗教信仰和精神性与更好的药物依从性相关。
Zotero 插件